Treating female heart failure patients with metoprolol CR/XL

Jalal K. Ghali; Ileana L. Piña; Stephen S. Gottlieb; Prakash C. Deedwania; John C. Wikstrand

Treating female heart failure patients with metoprolol CR/XL

Jalal K. Ghali, Ileana L. Piña, Stephen S. Gottlieb, Prakash C. Deedwania, John C. Wikstrand

Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

We examined the effect of metoprolol controlled release/extended release (CR/XL) in 898 female patients participating in the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure. There was a 21 reduction in the primary end points of total mortality and all-cause hospitalization. There was also a decrease in all-cause (15%), cardiovascular-cause (29%), and heart-failure hospitalization (42%). These data show the therapeutic benefit of beta blocking agents in women with heart failure.

Original language	English (US)
Pages (from-to)	29-32
Number of pages	4
Journal	Cardiology Review
Volume	19
Issue number	12
State	Published - Oct 1 2002

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

@article{6523eac7a4804cff8dc9bb7d227e56c7,

title = "Treating female heart failure patients with metoprolol CR/XL",

abstract = "We examined the effect of metoprolol controlled release/extended release (CR/XL) in 898 female patients participating in the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure. There was a 21 reduction in the primary end points of total mortality and all-cause hospitalization. There was also a decrease in all-cause (15%), cardiovascular-cause (29%), and heart-failure hospitalization (42%). These data show the therapeutic benefit of beta blocking agents in women with heart failure.",

author = "Ghali, {Jalal K.} and Pi{\~n}a, {Ileana L.} and Gottlieb, {Stephen S.} and Deedwania, {Prakash C.} and Wikstrand, {John C.}",

year = "2002",

month = oct,

day = "1",

language = "English (US)",

volume = "19",

pages = "29--32",

journal = "Cardiology Board Review",

issn = "1092-6607",

publisher = "Ascend Media",

number = "12",

}

TY - JOUR

T1 - Treating female heart failure patients with metoprolol CR/XL

AU - Ghali, Jalal K.

AU - Piña, Ileana L.

AU - Gottlieb, Stephen S.

AU - Deedwania, Prakash C.

AU - Wikstrand, John C.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - We examined the effect of metoprolol controlled release/extended release (CR/XL) in 898 female patients participating in the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure. There was a 21 reduction in the primary end points of total mortality and all-cause hospitalization. There was also a decrease in all-cause (15%), cardiovascular-cause (29%), and heart-failure hospitalization (42%). These data show the therapeutic benefit of beta blocking agents in women with heart failure.

AB - We examined the effect of metoprolol controlled release/extended release (CR/XL) in 898 female patients participating in the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure. There was a 21 reduction in the primary end points of total mortality and all-cause hospitalization. There was also a decrease in all-cause (15%), cardiovascular-cause (29%), and heart-failure hospitalization (42%). These data show the therapeutic benefit of beta blocking agents in women with heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0036772278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036772278&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036772278

SN - 1092-6607

VL - 19

SP - 29

EP - 32

JO - Cardiology Board Review

JF - Cardiology Board Review

IS - 12

ER -

Treating female heart failure patients with metoprolol CR/XL

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this